Protokinetix, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
ProtoKinetix's 2024 10-K filing reveals increased operating losses and substantial doubt about the company's ability to continue as a going concern, despite reduced research and development spending.
OTC.Pink
ProtoKinetix, a biotechnology company focused on AAGP research, released its 10-K filing, outlining its financial status, research activities, and future plans.